Healthcare News: Key Takeaways

The UK has reprimanded Danish drugmaker Novo Nordisk for failing to disclose £7.8m in fees and expenses to UK healthcare professionals and organisations between 2020 and 2022. The reprimand follows a voluntary reporting by Novo Nordisk.

Roche will end development of a new immunotherapy drug for lung cancer after it failed to show a significant benefit compared with Merck’s Keytruda, halting progress on its much-anticipated tiragolumab.

Newly appointed UK Health Secretary Wes Streeting plans to discuss ending the latest junior doctors’ strike, continuing a long-running pay dispute. The BMA previously announced a five-day strike ahead of the UK national election.

The study found that type 2 diabetes patients taking GLP-1 drugs such as Novo Nordisk’s Ozempic have a lower risk of obesity-related cancers compared with patients taking insulin.

The Carlyle Group is close to acquiring Vantive, Baxter’s kidney care unit, for more than $4 billion, adding 4% to Baxter International’s stock value.

Germany has reported a rare outbreak of H7N5 bird flu in Bad Bentheim, near the Dutch border, that has killed 6,000 of nearly 91,000 birds, according to the World Organisation for Animal Health.

(Disclaimer: Based on information obtained from the agency.)